Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE451
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,794
Award facts
- Contract value 100% obligated
- $13,793.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,793.87 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on December 18, 2025, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent is a biologic medication commonly used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, making this delivery order part of the broader pharmaceutical support that AmerisourceBergen provides to military healthcare systems and the Defense Health Agency. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to federal customers. This award reflects the company's established capability to fulfill federal medical procurement requirements through open competition and its critical role in supporting the military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FE451?
SPE2DR26FE451 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FE451 worth?
The government has obligated $13,794 on SPE2DR26FE451.
Is contract SPE2DR26FE451 an order under another contract?
Yes. SPE2DR26FE451 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE451 competed?
The extent of competition for SPE2DR26FE451 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award